Zhang, Shuang
Cui, Qianwei
Yang, Shangying
Zhang, Fangxia
Li, Chunxia
Wang, Xiaoguang
Lei, Bo
Sheng, Xunlun
Funding for this research was provided by:
Ningxia Natural Science Foundation (2022AAC03388)
National Natural Science Foundation of China grants (82060183)
the Key Research and Development Project of Ningxia Hui Autonomous Region (2021BEG02045)
Article History
Received: 19 April 2023
Accepted: 15 October 2023
First Online: 22 November 2023
Declarations
:
: Our study adhered to the Declaration of Helsinki and followed the collection guidelines for human genetic disease specimens issued by the Ministry of Health of China and was approved and reviewed by the Ethics Committee on Human Research at People Hospital of Ningxia Hui Autonomous Region. Written informed consent was received from each participant or his or her legal guardians before participation.
: Written consent for the publication of identifying images or other personal or clinical details was obtained from study participants or their legal guardians for those under the age of 18. The proof of consent to publish from study participants and legal guardians can be requested at any time.
: We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, there. There is no professional or other personal interest of any nature or kind in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled, <i>“Exome and Genome Sequencing to Unravel the Precise Breakpoints of Partial Trisomy 6q and Partial Monosomy 2q”</i>.